ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
H

ESMO 2021 Update on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC: Final Results From KEYNOTE-355

By ecancer FEATURING Hope Rugo
By ecancer FEATURING Hope Rugo
407 views
October 20, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin
Breast Cancers
06:33
ecancer

EBCC 2024 Insights: "PRE-ACT Study - Evaluating AI Tool Predict…

Feat. T. Rattay
05:19
ecancer

EBCC 2024 Insights: "PREFERABLE-EFFECT Study - The Impact Exerc…

Feat. A. Hiensch
08:12
ecancer

KEYNOTE-756 Trial - Adding Pembro to Chemo Before and After BC Surge…

Feat. J. Cortes
23:30
ecancer

Global Trends & Inequalities in BC Survival & Care

Feat. C. Allemani, O. Ginsburg, V. Zadnik
15:48
ecancer

Global Trends & Inequalities in BC Survival & Care: Panel Di…

Feat. C. Allemani, O. Ginsburg, V. Zadnik
13:08
ecancer

The Latest Special Issue of Medical Science on the Use of Real-World…

Feat. S. Kar
03:57
ecancer

FABREC Study: Effectiveness of Short-Course Radiation vs. Standard T…

Feat. J. Wong
22:07
ecancer

Tailoring BC Treatments to Country Resources and Patients

Feat. H. Earl
14:31
ecancer

Tailoring BC Follow-Up Using Risk Predictions

Feat. S. Siesling
06:01
ecancer

TARGeted IORT INTRABEAM as a Treatment Option for Early Stage Breast…

Feat. E. Sperk
06:38
ecancer

Palbociclib Shows Improved PFS but Not Improved OS for ER+, HER2- mB…

Feat. B. Gyawali
16:56
ecancer

The RxPONDER Trial and Its Impact on Best Clinical Practice in HR+/H…

Feat. C. Markopoulos, G. Curigliano
10:45
ecancer

Tailoring Breast Cancer Radiation Therapy in the 21st Century

Feat. P. Poortmans
12:45
ecancer

ESMO 2021 Update on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC:…

Feat. H. Rugo
13:54
ecancer

Frontline Endocrine Therapy for Postmenopausal HR+, HER2- mBC: MONAL…

Feat. G. Hortobagyi
04:16
ecancer

ESMO 2021 Update on the Efficacy and Safety of [Vic-]Trastuzumab Duo…

Feat. C. Saura
11:31
ecancer

ESMO 2021: Summary of the Most Important Breast Cancer Trials

Feat. M. Lambertini
09:32
ecancer

BRCA Mutations mTNBC: Surveying Clinical Data of PARPi

Feat. N. El Saghir
10:38
ecancer

2020 ESMO Updates on BC: Atezo + (Nab-)Paclitaxel in Advanced TNBC, …

Feat. B. Gyawali
09:17
ecancer

Expert Analysis of Durvalumab + Olaparib/Paclitaxel in High-Risk HER…

Feat. L. Pusztai
07:03
ecancer

2020 ASCO Update on Newly Diagnosed mBC: Do Surgery and Radiation Af…

Feat. S. Khan
05:40
ecancer

2020 ESMO Update on Adjuvant CDK4/6i in Early HR+ BC: What Are the E…

Feat. M. Lambertini
08:08
ecancer

2020 ESMO Update on mTNBC: Is Sacituzumab Govitecan a Possible Stand…

Feat. M. Lambertini
06:12
ecancer

2020 ESMO Update on BC: Does Neoadjuvant Atezo/Chemo Combination Imp…

Feat. M. Lambertini
07:14
ecancer

2020 ESMO Update on ADCs in mTNBC: Is Sacituzumab Govitecan More Ben…

Feat. A. Bardia